Research Methodology – SGLT2 Inhibitors Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the SGLT2 Inhibitors Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the SGLT2 Inhibitors Market is developed by integrating key market indicators and macroeconomic variables. These include:
1 Factors considered while calculating market size and share
- Prevalence and incidence rate of diabetes in the global and regional levels.
- Pricing strategy of various SGLT2 inhibitors in different regional markets.
- R&D partnerships and collaborations among key industry players.
- Reimbursement policies and regulatory landscape for SGLT2 inhibitors.
- Usage and consumption rate of SGLT2 inhibitors, based on demographics and geography.
- New product launches and pipeline drugs in the market.
- Investments in research and development by pharmaceutical companies.
2 Key Market Indicators
- Global and regional prevalence and incidence of diabetes and obesity.
- Patient demographics and their healthcare expenditure.
- Revenue generated by SGLT2 inhibitors sales.
- Number of new product launches or approvals and their market penetration rates.
- Growth strategies adopted by key market players such as mergers, acquisitions, partnerships, collaborations, and new product developments.
- Government policies and regulatory guidelines related to SGLT2 inhibitors.
3 Growth Trends
- Increase in global diabetes population driving the demand for SGLT2 inhibitors.
- Emerging markets demonstrating high growth potential for SGLT2 inhibitors market.
- Technological advancements in drug discovery and clinical trials.
- Rise in geriatric population and associated increase in chronic diseases like diabetes.
- Growth in obesity rates worldwide leading to higher usage of SGLT2 inhibitors.
- Increased focus on early diabetes diagnosis and management.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the SGLT2 Inhibitors Market. Key inputs include:
Company-Level Information
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
Industry and Government Sources
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the SGLT2 Inhibitors Market
Market Intelligence Sources
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
Macro & Consumer Insights
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
Expert Insights & KOL Engagements
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
Focused Discussions & Panels
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
Data Validation & Business POV
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
Forecasting is carried out using proprietary models that combine:
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights